Medigene AG: Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells
- Synergies between the recombinant T cell technologies of Medigene and self-delivering RNAi technologies from RXi Pharm…
- Synergies between the recombinant T cell technologies of Medigene and self-delivering RNAi technologies from RXi Pharm…
Die Medigene AG (FWB: MDG1, Prime Standard, TecDAX) gibt ihre Teilnahme an sechs bevorstehenden Wissenschafts-, Investor…
Medigene AG (MDG1, Frankfurt, Prime Standard, TecDAX) announces that a scientific article on a method to identify T cell…
Die Medigene AG (FWB: MDG1, Prime Standard, TecDAX) gibt ihre Teilnahme an vier bevorstehenden Wissenschafts- und Busine…
Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced its participation at four upcoming scientific and busine…
Medigene AG (FSE: MDG1, Prime Standard, TecDAX), will demonstrate the use of its automated high-throughput screening (HT…
- Automated in vitro testing could reveal better neoantigens that activate more effective killer T cell responses - Two…
. - First poster reports of a semi-automated method for the isolation and initial characterization of neoantigen-specif…
Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced the appointment of eight leading experts to its new immu…
Die Medigene AG (FWB: MDG1, Prime Standard, TecDAX) gab heute die Ernennung von acht führenden Experten für einen neuen,…